Night after night, sleep is often treated as a fixed biological state, something that can be captured, measured, and neatly categorised within a single laboratory test.
New research is now challenging that assumption, pointing to a far more dynamic picture of sleep health and raising fresh concerns about hidden risks to the heart that may be going unnoticed in millions of people.
Two large studies led by Australian researchers suggest that dramatic night‑to‑night changes in obstructive sleep apnoea severity are linked to a substantially higher likelihood of serious cardiovascular disease.
The findings, published in the peer‑reviewed journals Sleep, indicate that variability in breathing disruptions during sleep may be just as important as average severity, and in some cases even more revealing.
The headline figure is striking. People whose sleep apnoea fluctuates widely from one night to the next were found to be around 30 per cent more likely to have experienced a heart attack, stroke, or heart failure. This elevated risk persisted even after researchers adjusted for how severe their sleep apnoea was on average, as well as for other common cardiovascular risk factors.
For years, obstructive sleep apnoea has been recognised as a major public health issue. Characterised by repeated collapses of the upper airway during sleep, it leads to intermittent drops in oxygen levels, frequent micro‑awakenings, and fragmented sleep architecture. It is commonly associated with loud snoring, morning headaches, poor concentration, and excessive daytime sleepiness.
Beyond these immediate symptoms, apnoea has long been linked to high blood pressure, heart rhythm disturbances, coronary artery disease, and stroke.
What has been less clear is why some people with relatively mild apnoea go on to develop serious heart problems, while others with more severe disease appear to fare better. The new research adds an important piece to that puzzle by focusing not on a single measurement, but on patterns over time.
“Two people with similar overall apnoea scores could have very different heart risks depending on how stable or unstable their nightly breathing was”
In the first study, scientists analysed data from more than 3,000 adults who monitored their breathing at home over several months using an under‑mattress sensor. This unobtrusive device recorded breathing patterns night after night in a real‑world setting, rather than in a sleep laboratory. The researchers then compared these long‑term sleep measurements with self‑reported histories of heart attack, stroke, and heart failure.
The results revealed a clear pattern. Individuals whose apnoea severity showed large swings between nights had a significantly higher prevalence of cardiovascular disease. Importantly, this association remained even when the researchers accounted for average apnoea severity, age, sex, body mass index, smoking, and other relevant factors.
In other words, two people with similar overall apnoea scores could have very different heart risks depending on how stable or unstable their nightly breathing was.
Experts involved in the work suggest that this instability may place repeated stress on the cardiovascular system. One night of relatively mild breathing disturbance may be followed by another marked by frequent oxygen drops and intense sleep fragmentation. Over time, the body may struggle to adapt to these repeated physiological shocks. Blood vessels, the heart muscle, and regulatory systems that control blood pressure and heart rate may be pushed into a state of chronic strain.
This perspective challenges the current standard approach to diagnosing sleep apnoea. Most people referred for testing undergo either a single overnight sleep study in a laboratory or a one‑night home sleep test. While these methods can identify apnoea, they provide only a snapshot.
For individuals whose condition varies substantially from night to night, that snapshot may be misleading. A relatively calm night could lead to an underestimation of risk, while a particularly bad night might exaggerate severity.
“Perhaps most striking was the discovery that people with mild apnoea but high variability had blood vessel health comparable to those with severe apnoea”
The idea that sleep should be viewed as a moving picture rather than a still image is reinforced by the second study, published in npj Digital Medicine. This research followed nearly 30,000 people across multiple countries over several years, using home‑based digital health devices to track sleep‑disordered breathing and related indicators.
Rather than focusing solely on clinical cardiovascular events, the researchers examined vascular ageing, a process that reflects the gradual stiffening and deterioration of blood vessels. Accelerated vascular ageing is widely regarded as an early warning sign for future heart disease and stroke.
The findings were consistent with the earlier study, and in some ways even more revealing. More severe sleep apnoea was associated with faster vascular ageing, as expected. However, high night‑to‑night variability in breathing disturbances also showed a strong association, independent of average severity. Habitual snoring, often dismissed as a nuisance rather than a medical issue, was linked to similar changes.
Perhaps most striking was the discovery that people with mild apnoea but high variability had blood vessel health comparable to those with severe apnoea. This suggests the existence of a large, previously hidden group of individuals who may not meet traditional thresholds for concern but who nonetheless carry a significant cardiovascular burden.
Together, the two studies point to a broader shift in how sleep health may need to be assessed and managed. Repeated measurements over time are already standard practice for many chronic conditions. Blood pressure is not diagnosed on the basis of a single reading. Blood glucose control is assessed through long‑term markers. Cholesterol levels are monitored periodically. Sleep, by contrast, has remained largely confined to one‑off testing.
“From a public health perspective, the implications are significant. Heart disease remains the leading cause of death worldwide, responsible for millions of deaths each year”
Advances in home‑based monitoring technology are beginning to change that landscape. Under‑mattress sensors, wearable devices, and other digital tools now allow sleep and breathing patterns to be tracked continuously over weeks, months, or even years. This opens the door to identifying patterns that would be invisible in a laboratory setting, including variability, trends, and responses to lifestyle changes or treatment.
From a public health perspective, the implications are significant. Heart disease remains the leading cause of death worldwide, responsible for millions of deaths each year. Many of its risk factors, including high blood pressure, obesity, physical inactivity, and smoking, are modifiable. Sleep health is increasingly recognised as part of this risk profile, yet it is often overlooked or simplified.
The new evidence suggests that better sleep assessment could help identify cardiovascular risk earlier, particularly in people who might otherwise be reassured by a single normal or mildly abnormal test result. It also raises questions about how treatment decisions are made. Continuous positive airway pressure therapy, oral appliances, weight management, and positional therapy are among the options available for sleep apnoea. Understanding nightly variability could help clinicians tailor these interventions more precisely.
At the same time, the researchers are careful to note the limits of their findings. The studies show strong and consistent associations, but they do not prove that fluctuating sleep apnoea directly causes heart disease. It is possible that underlying factors, such as changes in sleep position, alcohol use, nasal congestion, stress, or co‑existing medical conditions, contribute both to variability in apnoea and to cardiovascular risk. Long‑term interventional studies will be needed to clarify cause and effect.
Nevertheless, the consistency of the results across different populations, devices, and outcomes strengthens the case that variability itself is an important signal. It also aligns with emerging understanding of how intermittent hypoxia and sleep fragmentation affect the body.
Repeated cycles of oxygen deprivation and re‑oxygenation can trigger inflammation, oxidative stress, and sympathetic nervous system activation, all of which are implicated in cardiovascular disease. When these cycles are unpredictable and intense, the physiological burden may be greater.
“Sleep, once considered a passive state, is increasingly recognised as an active pillar of health that interacts closely with the heart, brain, and metabolism”
For individuals, the message is not one of alarm, but of awareness. Persistent snoring, unrefreshing sleep, and daytime fatigue should not be ignored, even if a previous sleep test suggested only mild problems. Discussing symptoms with a health professional may lead to further assessment or monitoring, particularly if other risk factors for heart disease are present.
For clinicians and health systems, the findings highlight the potential value of integrating multi‑night sleep data into routine care. This does not necessarily mean replacing laboratory sleep studies, which remain essential for diagnosis and detailed analysis. Rather, it suggests complementing them with longer‑term, real‑world monitoring that captures the full complexity of sleep behaviour.
The research also underscores the growing role of digital health in preventive medicine. As technology becomes more accessible and accurate, it offers new ways to detect risk earlier and intervene before irreversible damage occurs.
Sleep, once considered a passive state, is increasingly recognised as an active pillar of health that interacts closely with the heart, brain, and metabolism.
In the end, the studies serve as a reminder that the body does not operate in averages. It responds to patterns, fluctuations, and cumulative stress. A heart exposed to wildly varying oxygen levels night after night may tell a different story from one assessed on a single calm evening in a clinic.
Listening to that story, and learning how to measure it properly, may prove crucial in reducing the global burden of cardiovascular disease.
The post Fluctuating Sleep Apnoea Linked to 30% Higher Risk of Heart Attack, Stroke, or Heart Failure first appeared on PP Health Malaysia.
